Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.

MLA

Burkhoff D, et al. “Transmyocardial Laser Revascularisation Compared with Continued Medical Therapy for Treatment of Refractory Angina Pectoris: A Prospective Randomised Trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.” Lancet, vol. 354, no. 9182, Sept. 1999, pp. 885–90. EBSCOhost, https://doi.org/10.1016/s0140-6736(99)08113-1.

APA

Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss J, Jones JW, ATLANTIC Investigators, Burkhoff, D., Schmidt, S., Schulman, S. P., Myers, J., Resar, J., Becker, L. C., Weiss, J., & Jones, J. W. (1999). Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet, 354(9182), 885–890. https://doi.org/10.1016/s0140-6736(99)08113-1

Chicago

Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss J, et al. 1999. “Transmyocardial Laser Revascularisation Compared with Continued Medical Therapy for Treatment of Refractory Angina Pectoris: A Prospective Randomised Trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison.” Lancet 354 (9182): 885–90. doi:10.1016/s0140-6736(99)08113-1.